Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Clinical impact of abdominal versus mediastinal metastases as a prognostic factor for poor outcomes following esophageal cancer surgery: a retrospective study

Fig. 2

Kaplan-Meier curves for S-RFS in all the patients. a There was no statistically significant difference between those with and without cMLNM in terms of S-RFS (p = 0.050). b A significant difference in S-RFS was observed between those with and without cALNM (3-year survival rates: 89.7 and 66.7%, respectively; p = 0.000). cMLNM: clinical mediastinal lymph node metastasis, S-RFS: systemic recurrence-free survival, cALNM: clinical abdominal lymph node metastasis

Back to article page